Janine Trevillyan



Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Janine Trevillyan is an infectious diseases physician and early career researcher with an emerging reputation in non-infectious HIV-related co-morbidities. Her infectious diseases fellowship was completed at the eminent clinical and research centers of the Alfred and Austin Hospitals in Melbourne, Australia and she then secured faculty appointments at the same institutions. She completed a PhD (Monash University) in 2015 following which she was awarded a highly competitive NHMRC early career fellowship which has supported a two year placement at the University of California, Los Angeles from July 2016. Dr Trevillyan’s research focuses on the pathogenesis and prevention of HIV associated co-morbidities, and particularly HIV and antiretroviral associated cardiovascular disease. This has included the initiation and coordination of a large multi-national randomized controlled trial assessing the impact of statins on atherosclerosis in HIV positive individuals at intermediate cardiovascular risk which has completed recruitment (final data mid-2018). She has ongoing projects investigating the impact of abacavir on platelet function, the predictors of chronic kidney injury in HIV positive individuals, and the contribution of bacterial co-infection to the progression of coronary artery disease, and a new focus on implementing preventative strategies in at risk populations. 

External positions

Reserach Fellow, University of California

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Obesity and Fat Metabolism in Human Immunodeficiency Virus-Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications

Godfrey, C., Bremer, A., Alba, D., Apovian, C., Koethe, J. R., Koliwad, S., Lewis, D., Lo, J., McComsey, G. A., Eckard, A., Srinivasa, S., Trevillyan, J., Palmer, C. & Grinspoon, S., 2 Jul 2019, In : Journal of Infectious Diseases. 220, 3, p. 420-431 12 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Open Access
13 Citations (Scopus)

Changes in plasma lipidome following initiation of antiretroviral therapy

Trevillyan, J. M., Wong, G., Puls, R., Petoumenos, K., Emery, S., Mellett, N. A., Mundra, P. A., Meikle, P. J., Hoy, J. F. & for the ALTAIR Study Group, 1 Aug 2018, In : PLoS ONE. 13, 8, 16 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
4 Citations (Scopus)

Increasing Prevalence and Risk of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Individuals: Changing Demographics over a 6-Year Period

Moso, M. A., Woolnough, E., Langham, F., Hoy, J. F., Cheng, A. C., Walker, R. G., Chrysostomou, A., Woolley, I., Weeraratne, A. & Trevillyan, J. M., 5 Mar 2018, In : Journal of Infectious Diseases. 217, 6, p. 1013-1015 3 p.

Research output: Contribution to journalLetterResearchpeer-review

4 Citations (Scopus)

Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals

Woolnough, E., Hoy, J., Cheng, A., Walker, R., Chrysostomou, A., Woolley, I. J., Langham, F., Moso, M. A., Weeraratne, A. & Trevillyan, J., 28 May 2018, In : AIDS. 32, 13, p. 1829-1835 7 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Prevalence of dental symptoms and access to dental care in an American HIV outpatient clinic

Trevillyan, J. M., Chang, J. J. & Currier, J. S., 1 Jul 2018, In : Oral Diseases. 24, 5, p. 866-867 2 p.

Research output: Contribution to journalLetterOtherpeer-review